Pricing Log in Create free account

BGM Group Ltd. (BGM) vs Organogenesis (ORGO)

BGM Group Ltd. and Organogenesis are both Drug Manufacturers Specialty & Generic companies. Organogenesis is the larger, with a market value of $142.8M against $114.7M — 1.2× the size. Organogenesis has negative trailing earnings, so its P/E is not meaningful; BGM Group Ltd. trades at 144×. BGM Group Ltd. has the higher net margin (1.96% vs −22.2%) and the higher return on invested capital (0.00% vs −20.0%). Across the 16 metrics below, BGM Group Ltd. leads on 8 and Organogenesis on 8.

Valuation

Metric BGM ORGO Drug Manufacturers Specialty & Generic median
P/E 144.17 n/m 19.25
P/S n/m 0.28 2.11
P/B n/m 0.86 1.78
Price to free cash flow n/m 6.11 16.14
EV/EBITDA n/m n/m 12.58
EV/Sales (0.09) 0.21 2.73
Earnings yield 0.69% (85.86%) (4.38%)
Free cash flow yield 0.00% 16.36% 0.00%

Profitability

Metric BGM ORGO Drug Manufacturers Specialty & Generic median
Gross margin 6.54% 70.35% 53.94%
Operating margin 0.00% (7.84%) 0.00%
Net margin 1.96% (22.23%) 0.00%
Free cash flow margin 0.00% 4.56% 0.00%
Return on equity 0.00% (53.31%) (0.40%)
Return on assets 0.00% (23.44%) (3.32%)
Return on invested capital 0.00% (19.97%) 0.00%

Growth

Metric BGM ORGO Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — 6.50% 10.01%
EPS growth (last fiscal year) 10.00% 1,600.00% 49.06%
Revenue growth, 5-year CAGR (5.39%) 10.77% 6.74%
Net income growth, 5-year CAGR 0.00% 3.04% 0.00%

Health

Metric BGM ORGO Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.07 0.05
Current ratio 1.25 3.52 2.31
Net debt to EBITDA 0.97 (1.14) 0.97

Dividend

Metric BGM ORGO Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric BGM ORGO Drug Manufacturers Specialty & Generic median
Market cap 114.71m 142.83m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack